Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B-cell receptor pathway inhibitor.

ABSTRACT:

SUBMITTER: Wierda WG 

PROVIDER: S-EPMC6587980 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature